Saroja Pharma Industries India Limited (NSE:SAROJA)
India
· Delayed Price · Currency is INR 33.00
+0.15 (0.46%)
Apr 28, 2026, 1:37 PM IST
NSE:SAROJA Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 733.63 | 537.27 | 406.69 | 501.93 | 556.33 | 366.62 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0 | Upgrade
|
| Revenue | 733.63 | 537.27 | 406.69 | 501.93 | 556.33 | 366.62 | Upgrade
|
| Revenue Growth (YoY) | 91.67% | 32.11% | -18.97% | -9.78% | 51.75% | 114.65% | Upgrade
|
| Cost of Revenue | 683.38 | 485.81 | 356.43 | 452.96 | 503.52 | 333.41 | Upgrade
|
| Gross Profit | 50.25 | 51.46 | 50.27 | 48.97 | 52.8 | 33.2 | Upgrade
|
| Selling, General & Admin | 15.28 | 14.96 | 16.43 | 15.57 | 13.36 | 10.08 | Upgrade
|
| Other Operating Expenses | 8.02 | 7.86 | 6.85 | 5.59 | 16.85 | 9.38 | Upgrade
|
| Operating Expenses | 24.51 | 23.96 | 24.22 | 21.83 | 30.66 | 19.69 | Upgrade
|
| Operating Income | 25.73 | 27.5 | 26.04 | 27.14 | 22.14 | 13.52 | Upgrade
|
| Interest Expense | -10.54 | -12.17 | -12.8 | -9.95 | -6.66 | -2.65 | Upgrade
|
| Interest & Investment Income | 0.36 | 0.36 | 0.24 | 0.13 | 0.1 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.72 | 0.72 | 0.28 | 0.84 | 1.58 | 0.12 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.4 | -1.92 | -1.7 | -3.25 | -1.36 | -0.67 | Upgrade
|
| EBT Excluding Unusual Items | 17.67 | 14.49 | 12.07 | 14.92 | 15.79 | 10.35 | Upgrade
|
| Pretax Income | 17.67 | 14.49 | 12.07 | 14.92 | 15.79 | 10.35 | Upgrade
|
| Income Tax Expense | 4.99 | 4.15 | 3.29 | 4.31 | 4.39 | 3.04 | Upgrade
|
| Net Income | 12.69 | 10.34 | 8.78 | 10.61 | 11.4 | 7.31 | Upgrade
|
| Net Income to Common | 12.69 | 10.34 | 8.78 | 10.61 | 11.4 | 7.31 | Upgrade
|
| Net Income Growth | 78.20% | 17.75% | -17.19% | -6.97% | 55.90% | 354.42% | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | -1.25% | 13.89% | 20.16% | 2.16% | 5.73% | 1992.20% | Upgrade
|
| EPS (Basic) | 3.17 | 2.57 | 2.49 | 3.61 | 3.96 | 2.69 | Upgrade
|
| EPS (Diluted) | 3.16 | 2.57 | 2.49 | 3.61 | 3.96 | 2.69 | Upgrade
|
| EPS Growth | 80.33% | 3.29% | -31.08% | -8.84% | 47.28% | -78.28% | Upgrade
|
| Free Cash Flow | 4.27 | -14.46 | -37.04 | -15.34 | -39.76 | -11.01 | Upgrade
|
| Free Cash Flow Per Share | 1.07 | -3.60 | -10.49 | -5.22 | -13.83 | -4.05 | Upgrade
|
| Gross Margin | 6.85% | 9.58% | 12.36% | 9.76% | 9.49% | 9.06% | Upgrade
|
| Operating Margin | 3.51% | 5.12% | 6.40% | 5.41% | 3.98% | 3.69% | Upgrade
|
| Profit Margin | 1.73% | 1.93% | 2.16% | 2.11% | 2.05% | 1.99% | Upgrade
|
| Free Cash Flow Margin | 0.58% | -2.69% | -9.11% | -3.06% | -7.15% | -3.00% | Upgrade
|
| EBITDA | 26.95 | 28.64 | 26.98 | 27.8 | 22.56 | 13.72 | Upgrade
|
| EBITDA Margin | 3.67% | 5.33% | 6.63% | 5.54% | 4.06% | 3.74% | Upgrade
|
| D&A For EBITDA | 1.21 | 1.14 | 0.94 | 0.65 | 0.42 | 0.21 | Upgrade
|
| EBIT | 25.73 | 27.5 | 26.04 | 27.14 | 22.14 | 13.52 | Upgrade
|
| EBIT Margin | 3.51% | 5.12% | 6.40% | 5.41% | 3.98% | 3.69% | Upgrade
|
| Effective Tax Rate | 28.22% | 28.64% | 27.24% | 28.89% | 27.81% | 29.37% | Upgrade
|
| Revenue as Reported | 738.8 | 539.12 | 408.63 | 503.51 | 559.57 | 367.47 | Upgrade
|
| Advertising Expenses | - | 1.38 | 1 | 1.14 | 1.2 | 1.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.